George Scangos' Bold Vision Post author:Sam Post published:October 24, 2017 Post category:BioPharma The former Biogen CEO is making waves at his new venture, Vir Biotechnology. Source: BioSpace You Might Also Like Bausch & Lomb Introduces Renu Advanced Formula Multi-Purpose Solution May 21, 2017 Rheos Medicines Launches with $60 Million March 21, 2018 Alder BioPharmaceuticals Announces Closing of $250M of 2.50% Convertible Senior Notes Due 2025 February 1, 2018
Alder BioPharmaceuticals Announces Closing of $250M of 2.50% Convertible Senior Notes Due 2025 February 1, 2018
